CANNAPHARMARX, INC. Impairment of Long-Lived Assets Held-for-use
CANNAPHARMARX, INC. (CPMD) reported Impairment of Long-Lived Assets Held-for-use of $171.36 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2025-08-14
- CANNAPHARMARX, INC. impairment of long-lived assets held-for-use for the quarter ending 2024-06-30 was $171.36K.
- CANNAPHARMARX, INC. impairment of long-lived assets held-for-use for the quarter ending 2022-03-31 was $146.08K, a 0.00% change year-over-year.
- CANNAPHARMARX, INC. impairment of long-lived assets held-for-use for the quarter ending 2021-12-31 was $0.00.
- CANNAPHARMARX, INC. impairment of long-lived assets held-for-use for the quarter ending 2021-09-30 was $0.00.
- CANNAPHARMARX, INC. impairment of long-lived assets held-for-use for fiscal 2020 was $146.08K.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2024-06-30 | $171.36K 10-Q · filed 2025-08-14 | $450.46K 10-Q · filed 2025-08-14 | ||
| 2022-03-31 | $146.08K 10-Q · filed 2022-05-23 | $146.08K derived: sum of 2 quarters · filed 2022-05-23 | $146.08K derived: sum of 3 quarters · filed 2022-05-23 | $146.08K derived: sum of 4 quarters · filed 2022-05-23 |
| 2021-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2022-05-23 | $0.00 derived: sum of 2 quarters · filed 2022-05-23 | $0.00 derived: sum of 3 quarters · filed 2022-05-23 | $146.08K 10-Q · filed 2022-05-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $146.08K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $146.08K 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | $146.08K 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $146.08K 10-K · filed 2022-04-15 |